3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as C-Met tyrosine kinase modulators

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Furet, Pascal,McCarthy, Clive,Schoepfer, Joseph,Stutz, Stefan

申请号：

AU2010280706

公开号：

AU2010280706A1

申请日:

2010.08.06

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

The invention relates to compounds of formula (I) and salts thereof, wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease； the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases； pharamaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner； processes for the preparation of a compound of formula (I).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/